Package 72626-2701-1

Brand: sofosbuvir and velpatasvir

Generic: velpatasvir and sofosbuvir
NDC Package

Package Facts

Identity

Package NDC 72626-2701-1
Digits Only 7262627011
Product NDC 72626-2701
Description

2 BLISTER PACK in 1 CARTON (72626-2701-1) / 14 TABLET, FILM COATED in 1 BLISTER PACK

Marketing

Marketing Status
Marketed Since 2018-11-14
Brand sofosbuvir and velpatasvir
Generic velpatasvir and sofosbuvir
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "314b9ef7-c6e5-44c9-9fbf-b0d35a24cd7d", "openfda": {"nui": ["N0000191493", "N0000191258", "N0000191256", "N0000190113", "N0000185503", "N0000190107", "N0000190108", "N0000190109"], "unii": ["WJ6CA3ZU8B", "KCU0C7RS7Z"], "rxcui": ["1799212"], "spl_set_id": ["d0c1a945-4440-4b5c-81aa-693ed3db597c"], "pharm_class_epc": ["Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]", "Hepatitis C Virus NS5A Inhibitor [EPC]"], "pharm_class_moa": ["RNA Replicase Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]"], "manufacturer_name": ["Asegua Therapeutics LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (72626-2701-1)  / 14 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "72626-2701-1", "marketing_start_date": "20181114"}], "brand_name": "Sofosbuvir and Velpatasvir", "product_id": "72626-2701_314b9ef7-c6e5-44c9-9fbf-b0d35a24cd7d", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Hepatitis C Virus NS5A Inhibitor [EPC]", "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "RNA Replicase Inhibitors [MoA]"], "product_ndc": "72626-2701", "generic_name": "Velpatasvir and Sofosbuvir", "labeler_name": "Asegua Therapeutics LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sofosbuvir and Velpatasvir", "active_ingredients": [{"name": "SOFOSBUVIR", "strength": "400 mg/1"}, {"name": "VELPATASVIR", "strength": "100 mg/1"}], "application_number": "NDA208341", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20181114", "listing_expiration_date": "20261231"}